Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture

British Journal of Pharmacology

Volumn 148, Issue 4, 2006, Pages 459-468

  Takhshid, Mohammad A ^a   Poyner, David R ^b   Chabot, Jean Guy ^c   Fournier, Alain ^d   Ma, Weiya ^c   Zheng, Wen Hua ^c   Owji, Ali A ^c,e   Quirion, Remi ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ASTON UNIVERSITY   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adrenomedullin; BIBN4096BS; Calcitonin gene related peptide; Calcitonin receptor like receptor; cAMP; CGRP; Receptor binding assays; Receptor activity modifying protein; Spinal cord

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP; OLCEGEPANT;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL POPULATION; CELL STIMULATION; DRUG EFFECT; EMBRYO; EMBRYO CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SPINAL CORD;

ADRENOMEDULLIN; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; CYCLIC AMP; FEMALE; IMMUNOHISTOCHEMISTRY; PEPTIDE FRAGMENTS; PIPERAZINES; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD;

EID: 33745103433     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706750     Document Type: Article

References (56)

1. BELLONI, A.S., ALBERTIN, G., FORNERIS, M.L. & NUSSDORFER, G.G. (2001). Proadrenomedullin-derived peptides as autocrine-paracrine regulators of cell growth. Histol. Histopathol., 16, 1263-1274.
2. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
3. CHAKRAVARTY, P., SUTHAR, T.P., COPPOCK, H.A., NICHOLL, C.G., BLOOM, S.R., LEGON, S. & SMITH, D.M. (2000). CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CL) and receptor activity modifying proteins (RAMPs) in rat tissues. Br. J. Pharmacol., 130, 189-195.
4. COPPOCK, H.A., OWJI, A.A., AUSTIN, C., UPTON, P.D., JACKSON, M.L., GARDINER, J.V., GHATEI, M.A., BLOOM, S.R. & SMITH, D.M. (1999). Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity. Biochem. J., 338, 15-22.
5. COTTRELL, G.S., ROOSTERMAN, D., MARVIZON, J.C., SONG, B., WICK, E., PIKIOS, S., WONG, H., BERTHELIER, C., TANG, Y., STERNINI, C., BUNNETT, N.W. & GRADY, E.F. (2005). Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J. Comp. Neurol., 490, 239-255.
6. CRIDLAND, R.A. & HENRY, J.L. (1988). Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II. Neuropeptides, 11, 23-32.
7. 8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmacol. Exp. Ther., 254, 123-128.
8. DENNIS, T., FOURNIER, A., ST PIERRE, S. & QUIRION, R. (1989). Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J. Pharmacol. Exp. Ther., 251, 718-725.
9. DOODS, H., HALLERMAYER, G., WU, D., ENTZEROTH, M., RUDOLF, K., ENGEL, W. & EBERLEIN, W. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol., 129, 420-423.
10. DUMONT, Y., CHABOT, J.-G. & QUIRION, R. (2004). Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides. Peptides, 25, 365-391.
11. ENTZEROTH, M., DOODS, H.N., WIELAND, H.A. & WIENEN, W. (1995). Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sci., 56, L19-L25.
12. FONTAINE, B., KLARSFELD, A., HOKFELT, T. & CHANGEUX, J.P. (1986). Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci. Lett., 71, 59-65.
13. GIBSON, S.J., POLAK, J.M., BLOOM, S.R., SABATE, I.M., MULDERRY, P.M., GHATEI, M.A., MCGREGOR, G.P., MORRISON, J.F., KELLY, J.S. & EVANS, R.M. (1984). Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J. Neurosci., 4, 3101-3111.
14. GOLTZMAN, D. & MITCHELL, J. (1985). Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science, 227, 1343-1345.
15. HAY, D.L., CONNER, A.C., HOWITT, S.G., SMITH, D.M. & POYNER, D.R. (2004a). The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J. Mol. Neurosci., 22, 105-114.
16. HAY, D.L., CONNER, A.C., HOWITT, S.G., TAKHSHID, M.A., SIMMS, J., MAHMOUD, K. & POYNER, D.R. (2004b). The pharmacology of CGRP-responsive receptors in cultured and transfected cells. Peptides, 25, 2019-2026.
17. 8-37 and BIBN4096BS. Br. J. Pharmacol., 140, 477-486.
18. HINSON, J.P., KAPAS, S. & SMITH, D.M. (2000). Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev., 21, 138-167.
19. HUSMANN, K., BORN, W., FISCHER, J.A. & MUFF, R. (2003). Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells. Biochem. Pharmacol., 66, 2107-2115.
20. JACQUES, D., DUMONT, Y., VAN ROSSUM, D. & QUIRION, R. (2000). Calcitonin gene-related peptide (CGRP), amylin and adrenomedullin anatomical localization and biological functions in the mammalian and human brains. In: Handbook of Chemical Neuroanatomy, ed. Quirion, R., Bjorklund, A. & Hokfelt, T. Vol. 16: Peptide Receptors, Part 1. pp. 301-374. Amsterdam: Elservier Science.
21. JUANEDA, C., DUMONT, Y. & QUIRION, R. (2000). The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol. Sci., 21, 432-438.
22. KUWASAKO, K., CAO, Y.N., NAGOSHI, Y., KITAMURA, K. & ETO, T. (2004). Adrenomedullin receptors: pharmacological features and possible pathophysiological roles. Peptides, 25, 2003-2012.
23. LEIGHTON, B. & COOPER, G.J. (1988). Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature, 335, 632-635.
24. MA, W. & QUIRION, R. (2006). Increased calcitonin gene-related peptide in neuroma and invading macrophages is involved in the up-regulation of interleukin-6 and thermal hyperalgesia in a rat model of mononeuropathy. J Neurochemistry (in press).
25. MA, W., ZHENG, W.H., KAR, S. & QUIRION, R. (2000). Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience, 99, 529-539.
26. MCLATCHIE, L.M., FRASER, N.J., MAIN, M.J., WISE, A., BROWN, J., THOMPSON, N., SOLARI, R., LEE, M.G. & FOORD, S.M. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature, 393, 333-339.
27. MENARD, D.P., VAN ROSSUM, D., KAR, S., JOLICOEUR, F.B., JHAMANDAS, K. & QUIRION, R. (1995a). Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites. J. Pharmacol. Exp. Ther., 273, 887-894.
28. MENARD, D.P., VAN ROSSUM, D., KAR, S. & QUIRION, R. (1995b). Alteration of calcitonin gene related peptide and its receptor binding sites during the development of tolerance to mu and delta opioids. Can. J. Physiol. Pharmacol., 73, 1089-1095.
29. MENARD, D.P., VAN ROSSUM, D., KAR, S., ST PIERRE, S., SUTAK, M., JHAMANDAS, K. & QUIRION, R. (1996). A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J. Neurosci., 16, 2342-2351.
30. MIYASHITA, K., ITOH, H., SAWADA, N., FUKUNAGA, Y., SONE, M., YAMAHARA, K., YURUGI, T. & NAKAO, K. (2003). Adrenomedullin promotes proliferation and migration of cultured endothelial cells. Hypertens. Res., 26 (Suppl), S93-S98.
31. MOGIL, J.S., MIERMEISTER, F., SEIFERT, F., STRASBURG, K., ZIMMERMANN, K., REINOLD, H., AUSTIN, J.-S., BERNARDINI, N., CHESLER, E.J., HOFMANN, H.A., HORDO, C., MESSLINGER, K., NEMMANI, K.V.S., RANKIN, A.J., RITCHIE, J., SIEGLING, A., SMITH, S.B., SOTOCINAL, S., VATER, A., WILSON, S.G., KLUSSMANN, S., QUIRION, R., MICHAELIS, M., DEVOR, M. & REEH, P.W. (2005). Variable sensitivity to noxious heat is mediated by differential expression of CGRP gene. Proc. Natl. Acad. Sci. U.S.A. 102, 12938-12943.
32. NAGOSHI, Y., KUWASAKO, K., ITO, K., UEMURA, T., KATO, J., KITAMURA, K. & ETO, T. (2002). The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor. Eur. J. Pharmacol., 450, 237-243.
33. NEW, H.V. & MUDGE, A.W. (1986). Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis. Nature, 323, 809-811.
34. OLIVER, K.R., KANE, S.A., SALVATORE, C.A., MALLEE, J.J., KINSEY, A.M., KOBLAN, K.S., KEYVAN-FOULADI, N., HEAVENS, R.P., WAINWRIGHT, A., JACOBSON, M., DICKERSON, I.M. & HILL, R.G. (2001). Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur. J. Neurosci., 14, 618-628.
35. OLIVER, K.R., WAINWRIGHT, A., HEAVENS, R.P., HILL, R.G. & SIRINATHSINGHJI, D.J. (1998). Distribution of novel CGRP1 receptor and adrenomedullin receptor mRNAs in the rat central nervous system. Mol. Brain Res., 57, 149-154.
36. OWJI, A.A., GARDINER, J.V., UPTON, P.D., MAHMOODI, M., GHATEI, M.A., BLOOM, S.R. & SMITH, D.M. (1996). Characterisation and molecular identification of adrenomedullin binding sites in the rat spinal cord: a comparison with calcitonin gene-related peptide receptors. J. Neurochem., 67, 2172-2179.
37. OWJI, A.A., MA, W., CHABOT, J.-G. & QUIRION, R. (2004). Adrenomedullin, A New Pain-Related Peptide of The Calcitonin Gene-Related Peptide Family. pp. Program No. 291.3, 2004 Abstract Viewer/Itinerary Planner.. Washington, DC: Society for Neuroscience.
38. OWJI, A.A., SMITH, D.M., COPPOCK, H.A., MORGAN, D.G., BHOGAL, R., GHATEI, M.A. & BLOOM, S.R. (1995). An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology, 136, 2127-2134.
39. PARSONS, A.M. & SEYBOLD, V.S. (1997). Calcitonin gene-related peptide induces the formation of second messengers in primary cultures of neonatal rat spinal cord. Synapse, 26, 235-242.
40. POWELL, K.J., MA, W., SUTAK, M., DOODS, H., QUIRION, R. & JHAMANDAS, K. (2000). Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br. J. Pharmacol., 131, 875-884.
41. POWELL, K.J., QUIRION, R. & JHAMANDAS, K. (2003). Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons. Eur. J. Neurosci., 18, 1572-1583.
42. POYNER, D.R., ANDREW, D.P., BROWN, D., BOSE, C. & HANLEY, M.R. (1992). Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. Br. J. Pharmacol., 105, 441-447.
43. POYNER, D.R., SEXTON, P.M., MARSHALL, I., SMITH, D.M., QUIRION, R., BORN, W., MUFF, R., FISCHER, J.A. & FOORD, S.M. (2002). International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev., 54, 233-246.
44. SALMON, A.M., DAMAJ, I., SEKINE, S., PICCIOTTO, M.R., MARUBIO, L. & CHANGEUX, J.P. (1999). Modulation of morphine analgesia in αCGRP mutant mice. Neuroreport, 10, 849-854.
45. SALMON, A.M., DAMAJ, I., SEKINE, S., PICCIOTTO, M.R., MARUBIO, L. & CHANGEUX, J.P. (2001). Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient mice. Nat. Neurosci., 4, 357-358.
46. SEMPLICINI, A., CEOLOTTO, G., BARITONO, E., MALENDOWICZ, L.K., ANDREIS, P.G., SARTORI, M., ROSSI, G.P. & NUSSDORFER, G.G. (2001). Adrenomedullin stimulates DNA synthesis of rat adrenal zona glomerulosa cells through activation of the mitogen-activated protein kinase-dependent cascade. J. Hypertens., 19, 599-602.
47. SERRANO, J., UTTENTHAL, L.O., MARTINEZ, A., FERNANDEZ, A.P., MARTINEZ DE VELASCO, J., ALONSO, D., BENTURA, M.L., SANTACANA, M., GALLARDO, J.R., MARTINEZ-MURILLO, R., CUTTITTA, F. & RODRIGO, J. (2000). Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy. Brain Res., 853, 245-268.
48. SHAN, J. & KRUKOFF, T.L. (2001). Distribution of preproadrenomedullin mRNA in the rat central nervous system and its modulation by physiological stressors. J. Comp. Neurol., 432, 88-100.
49. SHU, S.Y., JU, G. & FAN, L.Z. (1988). The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett., 85, 169-171.
50. TAKHSHID, M.A., OWJI, A.A., VASEI, M., PANJEHSHAHIN, M.R., TABEI, S.M., TABATABAEE, H.R. & AY, J. (2004). Expression of spinal cord Fos protein in response to intrathecal adrenomedullin and CGRP in conscious rats. Brain Res., 1020, 30-36.
51. UCHIDA, S., YAMAMOTO, H., IIO, S., MATSUMOTO, N., WANG, X.B., YONEHARA, N., IMAI, Y., INOKI, R. & YOSHIDA, H. (1990). Release of calcitonin gene-related peptide-like immunoreactive substance from neuromuscular junction by nerve excitation and its action on striated muscle. J. Neurochem., 54, 1000-1003.
52. UEZONO, Y., NAKAMURA, E., UEDA, Y., SHIBUYA, I., UETA, Y., YOKOO, H., YANAGITA, T., TOYOHIRA, Y., KOBAYASHI, H., YANAGIHARA, N. & WADA, A. (2001). Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin. Mol. Brain Res., 97, 59-69.
53. VAN ROSSUM, D., HANISCH, U.K. & QUIRION, R. (1997). Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev., 21, 649-678.
54. WU, D., EBERLEIN, W., RUDOLF, K., ENGEL, W., HALLERMAYER, G. & DOODS, H. (2000). Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et) (2, 7)]hCGRP-preferring receptor. Eur. J. Pharmacol., 400, 313-319.
55. XU, X.J., WIESENFELD-HALLIN, Z., VILLAR, M.J., FAHRENKRUG, J. & HOKFELT, T. (1990). On the role of galanin, substance P and other neuropeptides in primary sensory neurons of the rat: studies on spinal reflex excitability and peripheral axotomy. Eur. J. Neurosci., 2, 733-743.
56. ZIMMERMANN, U., FISCHER, J.A. & MUFF, R. (1995). Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells. Peptides, 16, 421-424.